Can Electronic Decision Support Improve Acute Heart Failure Care in EDs?
METHODOLOGY:
The researchers conducted a pilot study involving 234 patients with AHF discharged from two large urban EDs in Northern California from January 2023 to July 2023 to assess the feasibility and safety of a passive electronic alert system.
The study utilized a two-tiered clinical decision support system: an 'AHF Banner' to nudge providers and an opt-in 'AHF report' offering tailored medical recommendations and personalized 30-day risk estimates using the STRIDE-HF risk tool for SAEs.
The researchers assessed active prescriptions for beta-blockers (BBs), renin-angiotensin receptor system inhibitors (RASis), sodium-glucose transport protein 2 inhibitors (SGLT2is), and mineralocorticoid receptor antagonists (MRAs) at ED arrival, as well as the initiation of new classes within 72 hours of discharge.
Prior to the launch of the decision support tool, ED clinicians received two 30-minute education sessions on AHF care and incorporating the tool into standard workflows.
TAKEAWAY:
Overall, 21.8% had HF with reduced ejection fraction (HFrEF), 9.0% had HF with mildly reduced ejection fraction (HFmrEF), and 53.8% had HF with preserved ejection fraction (HFpEF).
At ED arrival, 68.6%, 66.7%, 25.5%, and 19.6% patients with HFrEF were on a RASi, a BB, an SGLT2i, and an MRA, respectively. In contrast, 42.9%, 66.7%, 14.3%, and 4.8% patients with HFmrEF were on a RASi, a BB, an SGLT2i, and an MRA, respectively. An SGLT2i was the most prescribed new medication at ED discharge, with nearly a 10% increase in the proportion of patients with an active prescription.
Among the 126 patients with HFpEF, only 4.8% were on an SGLT2i at ED arrival, and no new prescriptions for this medication class were issued at discharge.
The researchers found no 30-day SAEs, including death, cardiopulmonary resuscitation, balloon-pump insertion, intubation, initiation of dialysis, myocardial infarction, or coronary revascularization, among the 51 patients discharged with a very low predicted risk for HF.
Scientific news
Could Baseline MRIs Reshape Prostate Cancer Risk Assessment?Adding baseline MRI to conventional prostate cancer risk stratification could improve prognostic accuracy, potentially affecting active surveillance and treatment decisions for some patients, according to the investigators on a new trial.
Untreated Hypertension Tied to Alzheimer's Disease RiskOlder adults with untreated hypertension have a 36% increased risk for Alzheimer's disease (AD) compared with those without hypertension and a 42% increased risk for AD compared with those with treated hypertension.